Pharma-Bio Serv, Inc.
PBSV · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,320 | $19,518 | $19,782 | $24,408 |
| - Cash | $6,767 | $10,446 | $14,463 | $17,468 |
| + Debt | $194 | $347 | $487 | $617 |
| Enterprise Value | $6,747 | $9,419 | $5,807 | $7,557 |
| Revenue | $9,509 | $16,977 | $19,399 | $20,115 |
| % Growth | -44% | -12.5% | -3.6% | – |
| Gross Profit | $2,516 | $5,066 | $4,881 | $5,360 |
| % Margin | 26.5% | 29.8% | 25.2% | 26.6% |
| EBITDA | -$1,106 | $1,312 | $1,226 | -$3,781 |
| % Margin | -11.6% | 7.7% | 6.3% | -18.8% |
| Net Income | -$778 | $1,310 | $1,007 | -$2,089 |
| % Margin | -8.2% | 7.7% | 5.2% | -10.4% |
| EPS Diluted | -0.034 | 0.057 | 0.044 | -0.091 |
| % Growth | -159.5% | 30.4% | 148.2% | – |
| Operating Cash Flow | -$567 | $1,891 | $592 | $805 |
| Capital Expenditures | -$160 | -$7 | -$19 | -$11 |
| Free Cash Flow | -$726 | $1,884 | $573 | $794 |